Cellular, Pharmacological, and Biophysical Evaluation of Explanted Lungs from a Patient with Sickle Cell Disease and Severe Pulmonary Arterial Hypertension

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pulmonary Circulation

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/674754PMID 25006410PMCID PMC4070844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Altered expression and signal transduction of endothelin‐1 receptors in heritable and idiopathic pulmonary arterial hypertension

  2013cited by this paper
• The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe

  2013cited by this paper
• First Successful Lung Transplantation for Sickle Cell Disease with Severe Pulmonary Arterial Hypertension and Pulmonary Veno-Occlusive Disease

  2013cited by this paper
• Hemodynamic predictors of mortality in adults with sickle cell disease.

  2013cited by this paper
• Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47

  2013cited by this paper
• A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease

  2013cited by this paper
• Molecular mechanisms of superoxide production by the mitochondrial respiratory chain.

  2012cited by this paper
• Mortality in adults with sickle cell disease and pulmonary hypertension.

  2012cited by this paper
• Thrombospondin-1 Regulates Blood Flow via CD47 Receptor–Mediated Activation of NADPH Oxidase 1

  2012cited by this paper
• Pulmonary Arterial Hypertension: Classification and Therapy With a Focus on Prostaglandin Analogs

  2012influential reference
• Plasma thrombospondin‐1 is increased during acute sickle cell vaso‐occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates

  2012cited by this paper
• Characterization of altered patterns of endothelial progenitor cells in sickle cell disease related pulmonary arterial hypertension

  2012cited by this paper
• Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1.

  2012cited by this paper
• Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease

  2011cited by this paper
• Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.

  2011cited by this paper
• A hemodynamic study of pulmonary hypertension in sickle cell disease.

  2011cited by this paper
• Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling.

  2011cited by this paper
• Role of Thrombospondin-1 in pulmonary hypertension : a proof of concept

  2011cited by this paper
• Physiological Relevance of Antioxid/Redox Genes; Learning from Genetically Modified Animals Guest Editor: Junichi Fujii Physiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme

  2011cited by this paper
• Echocardiographic Markers of Elevated Pulmonary Pressure and Left Ventricular Diastolic Dysfunction Are Associated With Exercise Intolerance in Adults and Adolescents With Homozygous Sickle Cell Anemia in the United States and United Kingdom

  2011cited by this paper
• Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation.

  2010cited by this paper
• Redox signaling and reactive oxygen species in hypoxic pulmonary vasoconstriction.

  2010cited by this paper
• Sickle-cell disease

  2010cited by this paper
• Sickle cell disease serum induces NADPH enzyme subunit expression and oxidant production in leukocytes

  2010cited by this paper
• Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension.

  2010cited by this paper
• Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension.

  2010cited by this paper
• Segmentation and quantification of pulmonary artery for noninvasive CT assessment of sickle cell secondary pulmonary hypertension.

  2010cited by this paper
• Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension

  2010influential reference
• Differential Interactions of Thrombospondin-1, -2, and -4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses*

  2009cited by this paper
• Angiogenic and Inflammatory Markers of Cardiopulmonary Changes in Children and Adolescents with Sickle Cell Disease

  2009cited by this paper
• Collagen-related gene and protein expression changes in the lung in response to chronic hypoxia

  2009influential reference
• Cellular and molecular basis of pulmonary arterial hypertension.

  2009cited by this paper
• Molecular pathogenesis of pulmonary arterial hypertension.

  2008cited by this paper
• Changes in the structure-function relationship of elastin and its impact on the proximal pulmonary arterial mechanics of hypertensive calves.

  2008cited by this paper
• Thrombospondins: from structure to therapeutics

  2008cited by this paper
• Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.

  2008cited by this paper
• Pulmonary arterial hypertension and left‐sided heart disease in sickle cell disease: Clinical characteristics and association with soluble adhesion molecule expression

  2008cited by this paper
• Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease

  2007cited by this paper
• Sickle Cell Lung Disease and Sudden Death: A Retrospective/Prospective Study of 21 Autopsy Cases and Literature Review

  2007cited by this paper
• Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.

  2007cited by this paper
• Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation.

  2007cited by this paper
• Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.

  2006cited by this paper
• Treatment and prevention of stroke in children with sickle cell disease

  2006cited by this paper
• Pulmonary hypertension in patients with sickle cell disease: a longitudinal study

  2006cited by this paper
• CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1*

  2006cited by this paper
• Bone and joint disease in sickle cell disease.

  2005cited by this paper
• Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.

  2005cited by this paper
• Enhanced hypoxic pulmonary vasoconstriction in families of adults or children with idiopathic pulmonary arterial hypertension.

  2005cited by this paper
• Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

  2005cited by this paper
• The endothelin system in pulmonary arterial hypertension.

  2004cited by this paper
• Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

  2004cited by this paper
• Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

  2004cited by this paper
• Vasoactive factors in sickle cell disease: In vitro evidence for endothelin‐1‐mediated vasoconstriction

  2004cited by this paper
• Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization.

  2003cited by this paper
• The Role of Tetrahydrobiopterin in Superoxide Generation from eNOS: Enzymology and Physiological Implications

  2003cited by this paper
• Pathology and aspects of pathogenesis in pulmonary arterial hypertension.

  2003cited by this paper
• Nitric Oxide-dependent Generation of Reactive Species in Sickle Cell Disease

  2003cited by this paper
• Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

  2002cited by this paper
• Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival.

  2002cited by this paper
• Nitric oxide as a unique signaling molecule in the vascular system: a historical overview.

  2002cited by this paper
• Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases.

  2002cited by this paper
• Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

  2002cited by this paper
• Upregulation of collagens detected by gene array in a model of flow-induced pulmonary vascular remodeling.

  2002influential reference
• Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease

  2001cited by this paper
• Tyrosine nitration: Localisation, quantification, consequences for protein function and signal transduction

  2001cited by this paper
• Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease

  2000cited by this paper
• Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

  2000cited by this paper
• Alveolar hypoxia increases gene expression of extracellular matrix proteins and platelet-derived growth factor-B in lung parenchyma.

  1998influential reference
• Increased levels of endothelin-1 in plasma of sickle cell anemia patients.

  1998cited by this paper
• Influence of the nature of the porphyrin ligand on the nuclease activity of metalloporphyrin-oligonucleotide conjugates designed with cationic, hydrophobic or anionic metalloporphyrins.

  1997cited by this paper
• The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia

  1996cited by this paper
• Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture.

  1995cited by this paper
• The formation of peroxynitrite in vivo from nitric oxide and superoxide.

  1995cited by this paper
• Pulmonary arterial smooth muscle contractility in hypoxia-induced pulmonary hypertension.

  1994cited by this paper
• Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusion.

  1993cited by this paper
• Mechanical properties and structure of isolated pulmonary arteries remodeled by chronic hyperoxia.

  1987cited by this paper
• The FASEB Journal • Research Communication Protective effects of phosphodiesterase-4 (PDE-4)

  year unknowncited by this paper

• Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology

  2024cites this paper
• A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis

  2021cites this paper
• Ex Vivo Regional Mechanical Characterization of Porcine Pulmonary Arteries

  2021cites this paper
• CD47 as a potential biomarker for the early diagnosis of severe COVID-19

  2021cites this paper
• CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes.

  2021cites this paper
• A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature.

  2021cites this paper
• Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.

  2019cites this paper
• CD47 limits autophagy to promote acute kidney injury

  2019cites this paper
• Hemolysis‐induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension

  2018cites this paper
• Mechanobiological Feedback in Pulmonary Vascular Disease

  2018cites this paper
• Intertraffic of Endothelin 1 and Thrombospondin 1 between lungs and myocard via pulmonary circulation can alter cardiac loads , tissue integrity and atrial blood coagulability

  2017cites this paper
• Thrombospondin‐1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia

  2017cites this paper
• TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension

  2017cites this paper
• Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine

  2017cites this paper
• The Defective Arginine-Nitric Oxide Pathway in Sickle Cell Disease

  2017cites this paper
• Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer

  2017cites this paper
• Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.

  2017influential citation
• The matricellular protein TSP1 promotes human and mouse endothelial cell senescence through CD47 and Nox1

  2017cites this paper
• Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways

  2017cites this paper
• Pulmonary Arterial Stiffness: Toward a New Paradigm in Pulmonary Arterial Hypertension Pathophysiology and Assessment

  2016cites this paper
• The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy

  2016influential citation
• Microvessel Mechanobiology in Pulmonary Arterial Hypertension: Cause and Effect

  2015influential citation
• Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.

  2014cites this paper